Wells Fargo’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Wells Fargo’s Portfolio DOVA Stock Details DOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-53,628	Closed	-$1.5M	–	7025
2019 Q3	$1.5M	Sell	53,628 -3,663	-6%	-$59.3K	﹤0.01%	3558
2019 Q2	$808K	Sell	57,291 -32,445	-36%	-$309K	﹤0.01%	4047
2019 Q1	$798K	Sell	89,736 -36,760	-29%	-$298K	﹤0.01%	4042
2018 Q4	$959K	Sell	126,496 -141,544	-53%	-$2.28M	﹤0.01%	3878
2018 Q3	$5.62M	Sell	268,040 -112,415	-30%	-$2.68M	﹤0.01%	2556
2018 Q2	$11.4M	Buy	380,455 +42,819	+13%	+$1.17M	﹤0.01%	1965
2018 Q1	$9.16M	Buy	337,636 +20,713	+7%	+$620K	﹤0.01%	2093
2017 Q4	$9.13M	Sell	316,923 -7,364	-2%	-$202K	﹤0.01%	2067
2017 Q3	$7.87M	Buy	324,287 +124,287	+62%	+$2.95M	﹤0.01%	2150
2017 Q2	$4.46M	Buy	+200,000	New	+$4.21M	﹤0.01%	2550

Wells Fargo's DOVA Position: Q4 2019 in Review

Wells Fargo sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 53,628 shares — an estimated $1.5M sold.

Wells Fargo first reported a position in DOVA in Q2 2017 and held it in 10 quarters. The position peaked at $11.4M in Q2 2018. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

Wells Fargo reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Wells Fargo sold 53,628 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $1.5M.
Wells Fargo first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q2 2017 and held it in 10 quarters.
Wells Fargo's Dova Pharmaceuticals, Inc. Common Stock position peaked at $11.4M in Q2 2018.
0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Wells Fargo's 13F filing for Q4 2019, filed 14 Feb 2020.